121 related articles for article (PubMed ID: 1155020)
1. Proceedings: Para-o-methylation of dopamine in human brain.
Ebinger G; Verheyden R
Acta Neurol Belg; 1975; 75(2):111. PubMed ID: 1155020
[No Abstract] [Full Text] [Related]
2. Parkinson's disease: from brain homogenate to treatment.
Hornykiewicz O
Fed Proc; 1973 Feb; 32(2):183-90. PubMed ID: 4143953
[No Abstract] [Full Text] [Related]
3. Some remarks concerning the possible role of brain monoamines (dopamine, noradrenaline, serotonin) in mental disorders.
Hornykiewicz O
J Psychiatr Res; 1974; 11():249-53. PubMed ID: 4282386
[No Abstract] [Full Text] [Related]
4. The metabolism of brain dopamine in human parkinsonism.
Hornykiewicz O
Riv Patol Nerv Ment; 1970 Oct; 91(5):281-6. PubMed ID: 5525774
[No Abstract] [Full Text] [Related]
5. Regional serotonin levels in brain: a comparison of depressive suicides and alcoholic suicides with controls.
Cochran E; Robins E; Grote S
Biol Psychiatry; 1976 Jun; 11(3):283-94. PubMed ID: 938697
[TBL] [Abstract][Full Text] [Related]
6. Dopamine and homovanillic acid concentrations in the post-mortem brain in schizophrenia [proceedings].
Bird ED; Crow TJ; Iversen LL; Longden A; Mackay AV; Riley GJ; Spokes EG
J Physiol; 1979 Aug; 293():36P-37P. PubMed ID: 501607
[No Abstract] [Full Text] [Related]
7. [The role of dopamine in the physiology and pathology of the basal ganglia].
Arushanian EB
Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(4):595-603. PubMed ID: 4341763
[No Abstract] [Full Text] [Related]
8. Proceedings: The ontogenesis of cerebral dopamine metabolism in the pig.
Fry JP; Sharman DF; Stephens DB
Br J Pharmacol; 1976 Mar; 56(3):372P. PubMed ID: 1260200
[No Abstract] [Full Text] [Related]
9. Thalamic control of dopaminergic functions in the caudate-putamen of the rat--II. Studies using ibotenic acid injection of the parafascicular-intralaminar nuclei.
Kilpatrick IC; Jones MW; Johnson BJ; Cornwall J; Phillipson OT
Neuroscience; 1986 Nov; 19(3):979-90. PubMed ID: 3796824
[TBL] [Abstract][Full Text] [Related]
10. Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains.
Kumar AM; Fernandez JB; Singer EJ; Commins D; Waldrop-Valverde D; Ownby RL; Kumar M
J Neurovirol; 2009 May; 15(3):257-74. PubMed ID: 19499455
[TBL] [Abstract][Full Text] [Related]
11. Effects of chronically administered L-dopa in normal and lesioned cats.
Langelier P; Roberge AG; Boucher R; Poirier LJ
J Pharmacol Exp Ther; 1973 Oct; 187(1):15-26. PubMed ID: 4746324
[No Abstract] [Full Text] [Related]
12. Thalamic control of dopaminergic functions in the caudate-putamen of the rat--I. The influence of electrical stimulation of the parafascicular nucleus on dopamine utilization.
Kilpatrick IC; Phillipson OT
Neuroscience; 1986 Nov; 19(3):965-78. PubMed ID: 3796823
[TBL] [Abstract][Full Text] [Related]
13. Huntington's chorea. Deficiency of gamma-aminobutyric acid in brain.
Perry TL; Hansen S; Kloster M
N Engl J Med; 1973 Feb; 288(7):337-42. PubMed ID: 4345566
[No Abstract] [Full Text] [Related]
14. Evidence for descending pallido-nigral GABA-containing neurons.
McGeer PL; Fibiger HC; Maler L; Hattori T; McGeer EG
Adv Neurol; 1974; 5():153-60. PubMed ID: 4155231
[No Abstract] [Full Text] [Related]
15. Mapping neuronal activity of the basal ganglia in experimental models of Parkinson's disease: contributions of the [14C]2-deoxyglucose method.
Orzi F; Fornai F; Blandini F
Funct Neurol; 2000; 15(4):269-76. PubMed ID: 11213530
[No Abstract] [Full Text] [Related]
16. [3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy.
Bokobza B; Ruberg M; Scatton B; Javoy-Agid F; Agid Y
Eur J Pharmacol; 1984 Mar; 99(2-3):167-75. PubMed ID: 6734727
[TBL] [Abstract][Full Text] [Related]
17. Brain acetylcholinesterase in Parkinson's disease.
Rinne UK; Riekkinen P; Sonninen V; Laaksonen H
Acta Neurol Scand; 1973; 49(2):215-26. PubMed ID: 4718190
[No Abstract] [Full Text] [Related]
18. Dopamine and homovanillic acid concentrations in striatal and limbic regions of human brain.
Walsh FX; Stevens TJ; Langlais PJ; Bird ED
Ann Neurol; 1982 Jul; 12(1):52-5. PubMed ID: 7114818
[TBL] [Abstract][Full Text] [Related]
19. [3H]Nitrendipine binding sites are decreased in the substantia nigra and striatum of the brain from patients with Parkinson's disease.
Nishino N; Noguchi-Kuno SA; Sugiyama T; Tanaka C
Brain Res; 1986 Jul; 377(1):186-9. PubMed ID: 2942224
[TBL] [Abstract][Full Text] [Related]
20. [Biochemical bases of Parkinson disease].
Colucci d'Amato C; Puccini A; Cristillo A; Vizioli R
Recenti Prog Med; 1984 Oct; 75(10):889-901. PubMed ID: 6151219
[No Abstract] [Full Text] [Related]
[Next] [New Search]
